DexCom Inc (BSP:D1EX34)
R$ 9.65 0 (0%) Market Cap: 188.46 Bil Enterprise Value: 189.06 Bil PE Ratio: 48.19 PB Ratio: 15.88 GF Score: 74/100

Dexcom Inc at Bank of America Healthcare Conference Transcript

May 11, 2022 / 09:40PM GMT
Release Date Price: R$8.14 (-2.92%)
Travis Lee Steed
BofA Securities, Research Division - MD

I'm Travis Steed, medical device analyst at Bank of America Merrill Lynch. And up next, we're pleased to have DexCom, Jereme Sylvain, Executive Vice President and CFO. Welcome.

Jereme M. Sylvain
DexCom, Inc. - Executive VP, CFO & CAO

Thanks for being here. Thanks for having us here. Thanks, everybody, for coming out and seeing us. Good to see faces we recognize on screens, in-person again. So thank you.

Travis Lee Steed
BofA Securities, Research Division - MD

Great. I don't know if there's anything you wanted to open with or just jump into questions.

Jereme M. Sylvain
DexCom, Inc. - Executive VP, CFO & CAO

No. Let's jump into questions. I think it's a good time to talk about DexCom. Maybe a tough market environment, but a good time to talk about the company.

Questions & Answers

Travis Lee Steed
BofA Securities, Research Division - MD

Right. I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot